By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Visterra, Inc. 

One Kendall Square
Suite B3301
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-498-1070 Fax: 617-498-1073


SEARCH JOBS


Industry
Biotechnology






Company News
Visterra, Inc. Announces Publication Of Data Demonstrating The Effectiveness Of VIS410 Against Seasonal And Potential Pandemic Influenza Strains 8/18/2015 8:34:08 AM
Visterra, Inc. Announces Publication In The Journal Cell, Demonstrating That Novel Antibody, VIS513, Broadly Neutralizes All Four Serotypes Of Dengue Virus In Preclinical Studies 7/17/2015 9:11:24 AM
Visterra, Inc. Announces Presentation Of Data At International Influenza Meeting On The Efficacy Of VIS410 For Treatment Of A Deadly Strain Of Avian Influenza 6/2/2015 1:28:20 PM
Visterra, Inc. Announces Presentation Of Data At International Influenza Meeting On The Efficacy Of VIS410 For Treatment Of A Deadly Strain Of Avian Influenza 6/2/2015 11:33:00 AM
Visterra, Inc. Partners With A*STAR To Develop VIS513, A Monoclonal Antibody For Dengue 5/22/2015 10:42:49 AM
Visterra, Inc. Announces Additions To Its Management Team And Board Of Directors 10/31/2014 9:21:33 AM
Cambridge Biotech Visterra, Inc. Reels In $30 Million 10/2/2014 5:58:47 AM
Visterra, Inc. To Present Data At ICAAC On VIS513, Its Humanized Monoclonal Antibody That Targets A Conserved Site On The Dengue Virus E Protein 9/3/2014 11:05:35 AM
Visterra, Inc. To Present Data At ICAAC On VIS513, Its Humanized Monoclonal Antibody That Targets A Conserved Site On The Dengue Virus E Protein 9/3/2014 8:53:04 AM
Visterra, Inc. To Present At The 32nd Annual J.P. Morgan Healthcare Conference 1/13/2014 7:15:21 AM
12
//-->